Company: PTPI
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0001410578-25-000579
Chunk: 3

Company: Petros Pharmaceuticals, Inc.
Filing Date: 2025-03-31
Form: 10-K
Item: Item 12S
Chunk 3
---
ITEM 12.SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

Equity Compensation Plan Information

The following table sets forth additional information, as of December 31, 2024, about our Common Stock that may be issued upon the exercise of options and other rights under the 2020 Plan.

​​​​​​​​​    ​    ​​    (c) Number of securities ​​​​​​​ remaining available for​​(a) Number of securities​(b) Weighted-average ​ future issuance under ​​ to be issued upon exercise ​exercise price of​ equity compensation plans ​​of outstanding options,​ outstanding options,​(excluding securitiesPlan Category​  warrants and rights​ warrants and rights​ reflected in column (a))Equity compensation plans approved by security holders  420,133​$ 4.77  2,247,658Equity compensation plans not approved by security holders N/A​ N/A N/ATotal  420,133​$ 4.77  2,247,658

​

N/A - Not applicable

Security Ownership of Certain Beneficial Owners and Management

The following table sets forth information regarding beneficial ownership of our voting securities as of March 26, 2025 (i) by each person who is known by us to beneficially own more than 5% of our voting securities; (ii) by each of our named executive officers and directors; and (iii) by all of our executive officers and directors as a group. Unless otherwise indicated in the following table, the address for each person named in the table is: 1185 Avenue of the Americas, New York, NY 10036.

​​​​​​​​​​​​​​​​Number of​​​​​Number of​​​Shares of​​​​​Shares of​​​Series A​​​​​Common​​​Preferred​​​​​Stock​​​Stock​​​​    Benefically    ​ Benefically​​​Name and Address of Beneficial Owner    Owned (1)    Percentage of Class (2)     Owned (1)    Percentage of Class (2)​5% Stockholders ​